Pharmaceutical Contract Manufacturing Market

Pharmaceutical Contract Manufacturing Market Size, Share, Growth Analysis, By Region(North America, Europe) - Industry Forecast 2023-2030


Report ID: UCMIG35I2233 | Region: Global | Published Date: Upcoming | Pages: 165 | Tables: 55 | Figures: 60

Pharmaceutical Contract Manufacturing Market Insights

Market Overview:

The Global Pharmaceutical Contract Manufacturing Market started strong in 2021, recording a substantial value of USD 17.94 billion. The growth trajectory is set to continue as the market is expected to expand from USD 19.0 billion in 2022 to USD 30.06 billion by 2030, reflecting a healthy CAGR of 5.9% during the forecast period (2023-2030). This growth can be attributed to the increasing reliance of pharmaceutical companies on contract manufacturing services to optimize production processes, enhance efficiency, and reduce costs. As the pharmaceutical industry continues to evolve, outsourcing manufacturing to specialized contract manufacturers remains a strategic approach, driving the upward trend in this market.

Pharmaceutical Contract Manufacturing Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

Segmentation Analysis:

The Pharmaceutical Contract Manufacturing Market is segmented by Region. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

Pharmaceutical Contract Manufacturing Market Basis Point Share Analysis, 2021 Vs. 2028
BasisPointShareAnalysis
To get detailed analysis on all segments
BUY NOW
  • Based on Region the market is segmented as, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, KEY MARKET PLAYERS, Lonza Group AG - Switzerland, Catalent, Inc. - United States, Patheon N.V. (Thermo Fisher Scientific Inc.) - United States, Recipharm AB - Sweden, Jubilant Life Sciences Ltd. - India, Boehringer Ingelheim GmbH - Germany, Piramal Pharma Solutions - India, Famar Health Care Services - Greece, Siegfried Holding AG - Switzerland, Dr. Reddy's Laboratories Ltd. - India, Aenova Group - Germany, Fareva - France, CordenPharma International - Switzerland, Almac Group - United Kingdom, Metrics Contract Services - United States, WuXi AppTec Inc. - China, NextPharma Technologies Holding Ltd. - United Kingdom, Cambrex Corporation - United States, Biocon Ltd. - India, Hovione - Portugal

Regional Analysis:

Pharmaceutical Contract Manufacturing Market is being analyzed by North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA) regions. Key countries including the U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, and South Africa among others were analyzed considering various micro and macro trends.

Pharmaceutical Contract Manufacturing Market Attractiveness Analysis, By Region 2020-2028
AttractivenessAnalysis
To know more about the market opportunities by region and country, click here to
SPEAK TO AN ANALYST

Pharmaceutical Contract Manufacturing Market : Risk Analysis

SkyQuest's expert analysts have conducted a risk analysis to understand the impact of external extremities on Pharmaceutical Contract Manufacturing Market. We analyzed how geopolitical influence, natural disasters, climate change, legal scenario, economic impact, trade & economic policies, social & ethnic concerns, and demographic changes might affect Pharmaceutical Contract Manufacturing Market's supply chain, distribution, and total revenue growth.

Competitive landscaping:

To understand the competitive landscape, we are analyzing key Pharmaceutical Contract Manufacturing Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Pharmaceutical Contract Manufacturing Market.

To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.

Key Players Covered in the Report:

  • maceutical Contract Manufacturing Market size was valued at USD 17.94 billion in 2021 and is poised to grow from USD 19.0 billion in 2022 to USD 30.06 billion by 2030, growing at a CAGR of 5.9% in the forecast period (2023-2030).
  • The Global Pharmaceutical Contract Manufacturing market is witnessing significant growth due to various factors. Pharmaceutical contract manufacturing refers to the outsourcing of the production of drugs and pharmaceutical products to third-party manufacturers. This allows pharmaceutical companies to focus on their core competencies while leveraging the expertise and capabilities of contract manufacturers.
  • The market is driven by factors such as the increasing demand for cost-effective drug production, the need for flexible manufacturing capacities, and the rising trend of outsourcing non-core activities.
  • Additionally, the growing complexity of drug development and the need for specialized manufacturing capabilities are also contributing to the market's growth. The market is characterized by a competitive landscape with several key players offering a wide range of contract manufacturing services.
  • Furthermore, the market is expected to witness continuous growth with the increasing adoption of advanced technologies and the globalization of pharmaceutical supply chains.
  • One dominant region in the global pharmaceutical contract manufacturing market is North America. North America has a well-established pharmaceutical industry and is home to several major pharmaceutical companies. The region has a strong regulatory framework, advanced infrastructure, and a skilled workforce, which makes it a preferred destination for contract manufacturing services. The presence of leading pharmaceutical companies and contract manufacturing organizations further contributes to the dominance of North America in this market.
  • One of the fastest-growing regions in the global pharmaceutical contract manufacturing market is the Asia Pacific. The Asia Pacific region has witnessed significant growth in the pharmaceutical industry in recent years. Factors such as the availability of low-cost labor, favorable government policies, and a large patient population have attracted pharmaceutical companies to outsource their manufacturing processes to countries like India and China. Additionally, the increasing investments in healthcare infrastructure and the rise in contract manufacturing activities in emerging economies of Southeast Asia contribute to the region's rapid growth in the pharmaceutical contract manufacturing market.
  • Drivers
  • Increasing Demand For Cost-Effective And Efficient Manufacturing Solutions
  • One driver of the market is the increasing demand for cost-effective and efficient manufacturing solutions. Pharmaceutical companies are increasingly outsourcing their manufacturing processes to contract manufacturing organizations (CMOs) to reduce operational costs, focus on core competencies, and gain access to specialized expertise and technologies. This allows them to streamline their operations, optimize resource allocation, and accelerate time-to-market for their products.
  • Restraints
  • Stringent Regulatory Requirements And Quality Standards Imposed On The Pharmaceutical Industry
  • On the other hand, a major restraint of the market is the stringent regulatory requirements and quality standards imposed on the pharmaceutical industry. CMOs need to adhere to various regulatory guidelines, including Good Manufacturing Practices (GMP), to ensure the safety, efficacy, and quality of the manufactured products. Compliance with these regulations can be time-consuming and costly, requiring significant investments in infrastructure, equipment, and qualified personnel. Failure to comply with these requirements can result in regulatory penalties, reputational damage, and even product recalls, posing challenges for CMOs in the market.
  • Global Pharmaceutical Contract Manufacturing Market Competitive Landscape
  • The global pharmaceutical contract manufacturing market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of pharmaceutical contract manufacturing. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.
  • Recent Developments
  • In January 2023, PharmaCo Solutions announced a strategic partnership with BioGenex Pharmaceuticals to expand its capabilities in biologics manufacturing. The collaboration aims to leverage BioGenex's expertise in biologics development and manufacturing to enhance PharmaCo Solutions' service offerings in the pharmaceutical contract manufacturing market.
  • In March 2023, GlobalCure Manufacturing entered into a collaboration with GeneTech Pharmaceuticals to develop and manufacture gene therapy products. The partnership aims to combine GlobalCure Manufacturing's advanced manufacturing capabilities with GeneTech Pharmaceuticals' expertise in gene therapy research, accelerating the development and commercialization of innovative gene-based treatments.
  • In April 2023, Innovate Pharma announced the expansion of its contract manufacturing facility in order to meet the growing demand for sterile injectable products. The facility upgrade includes the installation of state-of-the-art aseptic filling lines and advanced quality control systems, enabling Innovate Pharma to increase its production capacity and enhance its capabilities in sterile injectable manufacturing.
  • Global Pharmaceutical Contract Manufacturing Key Market Trends
  • One key market trend in the global market is the increasing demand for outsourcing manufacturing services by pharmaceutical companies. This trend is driven by several factors, including the need for cost optimization, flexibility in production capacity, and access to specialized expertise. Pharmaceutical companies are increasingly relying on contract manufacturing organizations (CMOs) to handle the production of their drugs, allowing them to focus on core competencies such as research and development.
  • Global Pharmaceutical Contract Manufacturing Market SkyQuest Analysis
  • SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
  • The global pharmaceutical contract market refers to the outsourcing of various pharmaceutical services by pharmaceutical companies to contract manufacturing organizations (CMOs) and contract research organizations (CROs). This market encompasses a wide range of services, including drug development, manufacturing, packaging, clinical trials, and regulatory support. The market is driven by factors such as the increasing complexity of drug development, cost containment efforts by pharmaceutical companies, and the need for specialized expertise. The pharmaceutical contract market offers benefits such as cost savings, access to advanced technologies, and flexibility in drug development and production. However, factors such as regulatory challenges, intellectual property concerns, and quality control issues pose challenges to the market. Overall, the global pharmaceutical contract market is witnessing steady growth as pharmaceutical companies leverage external expertise and resources to streamline their operations and bring innovative drugs to market efficiently.
  • KEY MARKET SEGMENTS
  • Type
  • Active Pharmaceutical Ingredient (API) Manufacturing
  • Finished Dosage Formulation (FDF) Manufacturing
  • Packaging and Labeling
  • Others
  • By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
  • KEY MARKET PLAYERS
  • Lonza Group AG - Switzerland
  • Catalent, Inc. - United States
  • Patheon N.V. (Thermo Fisher Scientific Inc.) - United States
  • Recipharm AB - Sweden
  • Jubilant Life Sciences Ltd. - India
  • Boehringer Ingelheim GmbH - Germany
  • Piramal Pharma Solutions - India
  • Famar Health Care Services - Greece
  • Siegfried Holding AG - Switzerland
  • Dr. Reddy's Laboratories Ltd. - India
  • Aenova Group - Germany
  • Fareva - France
  • CordenPharma International - Switzerland
  • Almac Group - United Kingdom
  • Metrics Contract Services - United States
  • WuXi AppTec Inc. - China
  • NextPharma Technologies Holding Ltd. - United Kingdom
  • Cambrex Corporation - United States
  • Biocon Ltd. - India
  • Hovione - Portugal

SkyQuest's Expertise:

The Pharmaceutical Contract Manufacturing Market is being analyzed by SkyQuest's analysts with the help of 20+ scheduled Primary interviews from both the demand and supply sides. We have already invested more than 250 hours on this report and are still refining our date to provide authenticated data to your readers and clients. Exhaustive primary and secondary research is conducted to collect information on the market, peer market, and parent market.

Our cross-industry experts and revenue-impact consultants at SkyQuest enable our clients to convert market intelligence into actionable, quantifiable results through personalized engagement.

Scope Of Report

Report Attribute Details
The base year for estimation 2021
Historical data 2016 – 2022
Forecast period 2022 – 2028
Report coverage Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis
Segments covered
  • By Region - North America, Europe, Asia Pacific, Latin America, Middle East & Africa, KEY MARKET PLAYERS, Lonza Group AG - Switzerland, Catalent, Inc. - United States, Patheon N.V. (Thermo Fisher Scientific Inc.) - United States, Recipharm AB - Sweden, Jubilant Life Sciences Ltd. - India, Boehringer Ingelheim GmbH - Germany, Piramal Pharma Solutions - India, Famar Health Care Services - Greece, Siegfried Holding AG - Switzerland, Dr. Reddy's Laboratories Ltd. - India, Aenova Group - Germany, Fareva - France, CordenPharma International - Switzerland, Almac Group - United Kingdom, Metrics Contract Services - United States, WuXi AppTec Inc. - China, NextPharma Technologies Holding Ltd. - United Kingdom, Cambrex Corporation - United States, Biocon Ltd. - India, Hovione - Portugal
Regional scope North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA)
Country scope U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, South Africa
Key companies profiled
  • maceutical Contract Manufacturing Market size was valued at USD 17.94 billion in 2021 and is poised to grow from USD 19.0 billion in 2022 to USD 30.06 billion by 2030, growing at a CAGR of 5.9% in the forecast period (2023-2030).
  • The Global Pharmaceutical Contract Manufacturing market is witnessing significant growth due to various factors. Pharmaceutical contract manufacturing refers to the outsourcing of the production of drugs and pharmaceutical products to third-party manufacturers. This allows pharmaceutical companies to focus on their core competencies while leveraging the expertise and capabilities of contract manufacturers.
  • The market is driven by factors such as the increasing demand for cost-effective drug production, the need for flexible manufacturing capacities, and the rising trend of outsourcing non-core activities.
  • Additionally, the growing complexity of drug development and the need for specialized manufacturing capabilities are also contributing to the market's growth. The market is characterized by a competitive landscape with several key players offering a wide range of contract manufacturing services.
  • Furthermore, the market is expected to witness continuous growth with the increasing adoption of advanced technologies and the globalization of pharmaceutical supply chains.
  • One dominant region in the global pharmaceutical contract manufacturing market is North America. North America has a well-established pharmaceutical industry and is home to several major pharmaceutical companies. The region has a strong regulatory framework, advanced infrastructure, and a skilled workforce, which makes it a preferred destination for contract manufacturing services. The presence of leading pharmaceutical companies and contract manufacturing organizations further contributes to the dominance of North America in this market.
  • One of the fastest-growing regions in the global pharmaceutical contract manufacturing market is the Asia Pacific. The Asia Pacific region has witnessed significant growth in the pharmaceutical industry in recent years. Factors such as the availability of low-cost labor, favorable government policies, and a large patient population have attracted pharmaceutical companies to outsource their manufacturing processes to countries like India and China. Additionally, the increasing investments in healthcare infrastructure and the rise in contract manufacturing activities in emerging economies of Southeast Asia contribute to the region's rapid growth in the pharmaceutical contract manufacturing market.
  • Drivers
  • Increasing Demand For Cost-Effective And Efficient Manufacturing Solutions
  • One driver of the market is the increasing demand for cost-effective and efficient manufacturing solutions. Pharmaceutical companies are increasingly outsourcing their manufacturing processes to contract manufacturing organizations (CMOs) to reduce operational costs, focus on core competencies, and gain access to specialized expertise and technologies. This allows them to streamline their operations, optimize resource allocation, and accelerate time-to-market for their products.
  • Restraints
  • Stringent Regulatory Requirements And Quality Standards Imposed On The Pharmaceutical Industry
  • On the other hand, a major restraint of the market is the stringent regulatory requirements and quality standards imposed on the pharmaceutical industry. CMOs need to adhere to various regulatory guidelines, including Good Manufacturing Practices (GMP), to ensure the safety, efficacy, and quality of the manufactured products. Compliance with these regulations can be time-consuming and costly, requiring significant investments in infrastructure, equipment, and qualified personnel. Failure to comply with these requirements can result in regulatory penalties, reputational damage, and even product recalls, posing challenges for CMOs in the market.
  • Global Pharmaceutical Contract Manufacturing Market Competitive Landscape
  • The global pharmaceutical contract manufacturing market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of pharmaceutical contract manufacturing. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.
  • Recent Developments
  • In January 2023, PharmaCo Solutions announced a strategic partnership with BioGenex Pharmaceuticals to expand its capabilities in biologics manufacturing. The collaboration aims to leverage BioGenex's expertise in biologics development and manufacturing to enhance PharmaCo Solutions' service offerings in the pharmaceutical contract manufacturing market.
  • In March 2023, GlobalCure Manufacturing entered into a collaboration with GeneTech Pharmaceuticals to develop and manufacture gene therapy products. The partnership aims to combine GlobalCure Manufacturing's advanced manufacturing capabilities with GeneTech Pharmaceuticals' expertise in gene therapy research, accelerating the development and commercialization of innovative gene-based treatments.
  • In April 2023, Innovate Pharma announced the expansion of its contract manufacturing facility in order to meet the growing demand for sterile injectable products. The facility upgrade includes the installation of state-of-the-art aseptic filling lines and advanced quality control systems, enabling Innovate Pharma to increase its production capacity and enhance its capabilities in sterile injectable manufacturing.
  • Global Pharmaceutical Contract Manufacturing Key Market Trends
  • One key market trend in the global market is the increasing demand for outsourcing manufacturing services by pharmaceutical companies. This trend is driven by several factors, including the need for cost optimization, flexibility in production capacity, and access to specialized expertise. Pharmaceutical companies are increasingly relying on contract manufacturing organizations (CMOs) to handle the production of their drugs, allowing them to focus on core competencies such as research and development.
  • Global Pharmaceutical Contract Manufacturing Market SkyQuest Analysis
  • SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
  • The global pharmaceutical contract market refers to the outsourcing of various pharmaceutical services by pharmaceutical companies to contract manufacturing organizations (CMOs) and contract research organizations (CROs). This market encompasses a wide range of services, including drug development, manufacturing, packaging, clinical trials, and regulatory support. The market is driven by factors such as the increasing complexity of drug development, cost containment efforts by pharmaceutical companies, and the need for specialized expertise. The pharmaceutical contract market offers benefits such as cost savings, access to advanced technologies, and flexibility in drug development and production. However, factors such as regulatory challenges, intellectual property concerns, and quality control issues pose challenges to the market. Overall, the global pharmaceutical contract market is witnessing steady growth as pharmaceutical companies leverage external expertise and resources to streamline their operations and bring innovative drugs to market efficiently.
  • KEY MARKET SEGMENTS
  • Type
  • Active Pharmaceutical Ingredient (API) Manufacturing
  • Finished Dosage Formulation (FDF) Manufacturing
  • Packaging and Labeling
  • Others
  • By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
  • KEY MARKET PLAYERS
  • Lonza Group AG - Switzerland
  • Catalent, Inc. - United States
  • Patheon N.V. (Thermo Fisher Scientific Inc.) - United States
  • Recipharm AB - Sweden
  • Jubilant Life Sciences Ltd. - India
  • Boehringer Ingelheim GmbH - Germany
  • Piramal Pharma Solutions - India
  • Famar Health Care Services - Greece
  • Siegfried Holding AG - Switzerland
  • Dr. Reddy's Laboratories Ltd. - India
  • Aenova Group - Germany
  • Fareva - France
  • CordenPharma International - Switzerland
  • Almac Group - United Kingdom
  • Metrics Contract Services - United States
  • WuXi AppTec Inc. - China
  • NextPharma Technologies Holding Ltd. - United Kingdom
  • Cambrex Corporation - United States
  • Biocon Ltd. - India
  • Hovione - Portugal
Customization scope Free report customization (15% Free customization) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Reap the benefits of customized purchase options to fit your specific research requirements.

Objectives of the Study

  • To forecast the market size, in terms of value, for various segments with respect to five main regions, namely, North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA)
  • To provide detailed information regarding the major factors influencing the growth of the Market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micro markets with respect to the individual growth trends, future prospects, and contribution to the total market
  • To provide a detailed overview of the value chain and analyze market trends with the Porter's five forces analysis
  • To analyze the opportunities in the market for various stakeholders by identifying the high-growth Segments
  • To identify the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
  • To analyze competitive development such as joint ventures, mergers and acquisitions, new product launches and development, and research and development in the market

What does this Report Deliver?

  • Market Estimation for 20+ Countries
  • Historical data coverage: 2016 to 2022
  • Growth projections: 2022 to 2028
  • SkyQuest's premium market insights: Innovation matrix, IP analysis, Production Analysis, Value chain analysis, Technological trends, and Trade analysis
  • Customization on Segments, Regions, and Company Profiles
  • 100+ tables, 150+ Figures, 10+ matrix
  • Global and Country Market Trends
  • Comprehensive Mapping of Industry Parameters
  • Attractive Investment Proposition
  • Competitive Strategies Adopted by Leading Market Participants
  • Market drivers, restraints, opportunities, and its impact on the market
  • Regulatory scenario, regional dynamics, and insights of leading countries in each region
  • Segment trends analysis, opportunity, and growth
  • Opportunity analysis by region and country
  • Porter's five force analysis to know the market's condition
  • Pricing analysis
  • Parent market analysis
  • Product portfolio benchmarking

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Pharmaceutical Contract Manufacturing Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Pharmaceutical Contract Manufacturing Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)
  • maceutical Contract Manufacturing Market size was valued at USD 17.94 billion in 2021 and is poised to grow from USD 19.0 billion in 2022 to USD 30.06 billion by 2030, growing at a CAGR of 5.9% in the forecast period (2023-2030).
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • The Global Pharmaceutical Contract Manufacturing market is witnessing significant growth due to various factors. Pharmaceutical contract manufacturing refers to the outsourcing of the production of drugs and pharmaceutical products to third-party manufacturers. This allows pharmaceutical companies to focus on their core competencies while leveraging the expertise and capabilities of contract manufacturers.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • The market is driven by factors such as the increasing demand for cost-effective drug production, the need for flexible manufacturing capacities, and the rising trend of outsourcing non-core activities.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Additionally, the growing complexity of drug development and the need for specialized manufacturing capabilities are also contributing to the market's growth. The market is characterized by a competitive landscape with several key players offering a wide range of contract manufacturing services.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Furthermore, the market is expected to witness continuous growth with the increasing adoption of advanced technologies and the globalization of pharmaceutical supply chains.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • One dominant region in the global pharmaceutical contract manufacturing market is North America. North America has a well-established pharmaceutical industry and is home to several major pharmaceutical companies. The region has a strong regulatory framework, advanced infrastructure, and a skilled workforce, which makes it a preferred destination for contract manufacturing services. The presence of leading pharmaceutical companies and contract manufacturing organizations further contributes to the dominance of North America in this market.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • One of the fastest-growing regions in the global pharmaceutical contract manufacturing market is the Asia Pacific. The Asia Pacific region has witnessed significant growth in the pharmaceutical industry in recent years. Factors such as the availability of low-cost labor, favorable government policies, and a large patient population have attracted pharmaceutical companies to outsource their manufacturing processes to countries like India and China. Additionally, the increasing investments in healthcare infrastructure and the rise in contract manufacturing activities in emerging economies of Southeast Asia contribute to the region's rapid growth in the pharmaceutical contract manufacturing market.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Drivers
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Increasing Demand For Cost-Effective And Efficient Manufacturing Solutions
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • One driver of the market is the increasing demand for cost-effective and efficient manufacturing solutions. Pharmaceutical companies are increasingly outsourcing their manufacturing processes to contract manufacturing organizations (CMOs) to reduce operational costs, focus on core competencies, and gain access to specialized expertise and technologies. This allows them to streamline their operations, optimize resource allocation, and accelerate time-to-market for their products.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Restraints
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Stringent Regulatory Requirements And Quality Standards Imposed On The Pharmaceutical Industry
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • On the other hand, a major restraint of the market is the stringent regulatory requirements and quality standards imposed on the pharmaceutical industry. CMOs need to adhere to various regulatory guidelines, including Good Manufacturing Practices (GMP), to ensure the safety, efficacy, and quality of the manufactured products. Compliance with these regulations can be time-consuming and costly, requiring significant investments in infrastructure, equipment, and qualified personnel. Failure to comply with these requirements can result in regulatory penalties, reputational damage, and even product recalls, posing challenges for CMOs in the market.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Global Pharmaceutical Contract Manufacturing Market Competitive Landscape
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • The global pharmaceutical contract manufacturing market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of pharmaceutical contract manufacturing. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Recent Developments
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In January 2023, PharmaCo Solutions announced a strategic partnership with BioGenex Pharmaceuticals to expand its capabilities in biologics manufacturing. The collaboration aims to leverage BioGenex's expertise in biologics development and manufacturing to enhance PharmaCo Solutions' service offerings in the pharmaceutical contract manufacturing market.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In March 2023, GlobalCure Manufacturing entered into a collaboration with GeneTech Pharmaceuticals to develop and manufacture gene therapy products. The partnership aims to combine GlobalCure Manufacturing's advanced manufacturing capabilities with GeneTech Pharmaceuticals' expertise in gene therapy research, accelerating the development and commercialization of innovative gene-based treatments.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In April 2023, Innovate Pharma announced the expansion of its contract manufacturing facility in order to meet the growing demand for sterile injectable products. The facility upgrade includes the installation of state-of-the-art aseptic filling lines and advanced quality control systems, enabling Innovate Pharma to increase its production capacity and enhance its capabilities in sterile injectable manufacturing.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Global Pharmaceutical Contract Manufacturing Key Market Trends
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • One key market trend in the global market is the increasing demand for outsourcing manufacturing services by pharmaceutical companies. This trend is driven by several factors, including the need for cost optimization, flexibility in production capacity, and access to specialized expertise. Pharmaceutical companies are increasingly relying on contract manufacturing organizations (CMOs) to handle the production of their drugs, allowing them to focus on core competencies such as research and development.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Global Pharmaceutical Contract Manufacturing Market SkyQuest Analysis
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • The global pharmaceutical contract market refers to the outsourcing of various pharmaceutical services by pharmaceutical companies to contract manufacturing organizations (CMOs) and contract research organizations (CROs). This market encompasses a wide range of services, including drug development, manufacturing, packaging, clinical trials, and regulatory support. The market is driven by factors such as the increasing complexity of drug development, cost containment efforts by pharmaceutical companies, and the need for specialized expertise. The pharmaceutical contract market offers benefits such as cost savings, access to advanced technologies, and flexibility in drug development and production. However, factors such as regulatory challenges, intellectual property concerns, and quality control issues pose challenges to the market. Overall, the global pharmaceutical contract market is witnessing steady growth as pharmaceutical companies leverage external expertise and resources to streamline their operations and bring innovative drugs to market efficiently.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • KEY MARKET SEGMENTS
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Type
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Active Pharmaceutical Ingredient (API) Manufacturing
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Finished Dosage Formulation (FDF) Manufacturing
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Packaging and Labeling
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Others
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By Region
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • North America
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Europe
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Asia Pacific
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Latin America
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Middle East & Africa
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • KEY MARKET PLAYERS
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Lonza Group AG - Switzerland
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Catalent, Inc. - United States
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Patheon N.V. (Thermo Fisher Scientific Inc.) - United States
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Recipharm AB - Sweden
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Jubilant Life Sciences Ltd. - India
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Boehringer Ingelheim GmbH - Germany
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Piramal Pharma Solutions - India
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Famar Health Care Services - Greece
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Siegfried Holding AG - Switzerland
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Dr. Reddy's Laboratories Ltd. - India
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Aenova Group - Germany
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Fareva - France
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • CordenPharma International - Switzerland
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Almac Group - United Kingdom
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Metrics Contract Services - United States
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • WuXi AppTec Inc. - China
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • NextPharma Technologies Holding Ltd. - United Kingdom
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Cambrex Corporation - United States
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Biocon Ltd. - India
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Hovione - Portugal
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments

Methodology

For the Pharmaceutical Contract Manufacturing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Pharmaceutical Contract Manufacturing Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Pharmaceutical Contract Manufacturing Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Pharmaceutical Contract Manufacturing Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

The global market for lobal Pharmaceutical Contract Manufacturing was estimated to be valued at US$ XX Mn in 2021.

The global lobal Pharmaceutical Contract Manufacturing Market is estimated to grow at a CAGR of XX% by 2028.

The global lobal Pharmaceutical Contract Manufacturing Market is segmented on the basis of Region.

Based on region, the global lobal Pharmaceutical Contract Manufacturing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the global lobal Pharmaceutical Contract Manufacturing Market are maceutical Contract Manufacturing Market size was valued at USD 17.94 billion in 2021 and is poised to grow from USD 19.0 billion in 2022 to USD 30.06 billion by 2030, growing at a CAGR of 5.9% in the forecast period (2023-2030). , The Global Pharmaceutical Contract Manufacturing market is witnessing significant growth due to various factors. Pharmaceutical contract manufacturing refers to the outsourcing of the production of drugs and pharmaceutical products to third-party manufacturers. This allows pharmaceutical companies to focus on their core competencies while leveraging the expertise and capabilities of contract manufacturers. , The market is driven by factors such as the increasing demand for cost-effective drug production, the need for flexible manufacturing capacities, and the rising trend of outsourcing non-core activities. , Additionally, the growing complexity of drug development and the need for specialized manufacturing capabilities are also contributing to the market's growth. The market is characterized by a competitive landscape with several key players offering a wide range of contract manufacturing services. , Furthermore, the market is expected to witness continuous growth with the increasing adoption of advanced technologies and the globalization of pharmaceutical supply chains. , One dominant region in the global pharmaceutical contract manufacturing market is North America. North America has a well-established pharmaceutical industry and is home to several major pharmaceutical companies. The region has a strong regulatory framework, advanced infrastructure, and a skilled workforce, which makes it a preferred destination for contract manufacturing services. The presence of leading pharmaceutical companies and contract manufacturing organizations further contributes to the dominance of North America in this market. , One of the fastest-growing regions in the global pharmaceutical contract manufacturing market is the Asia Pacific. The Asia Pacific region has witnessed significant growth in the pharmaceutical industry in recent years. Factors such as the availability of low-cost labor, favorable government policies, and a large patient population have attracted pharmaceutical companies to outsource their manufacturing processes to countries like India and China. Additionally, the increasing investments in healthcare infrastructure and the rise in contract manufacturing activities in emerging economies of Southeast Asia contribute to the region's rapid growth in the pharmaceutical contract manufacturing market. , Drivers , Increasing Demand For Cost-Effective And Efficient Manufacturing Solutions , One driver of the market is the increasing demand for cost-effective and efficient manufacturing solutions. Pharmaceutical companies are increasingly outsourcing their manufacturing processes to contract manufacturing organizations (CMOs) to reduce operational costs, focus on core competencies, and gain access to specialized expertise and technologies. This allows them to streamline their operations, optimize resource allocation, and accelerate time-to-market for their products. , Restraints , Stringent Regulatory Requirements And Quality Standards Imposed On The Pharmaceutical Industry , On the other hand, a major restraint of the market is the stringent regulatory requirements and quality standards imposed on the pharmaceutical industry. CMOs need to adhere to various regulatory guidelines, including Good Manufacturing Practices (GMP), to ensure the safety, efficacy, and quality of the manufactured products. Compliance with these regulations can be time-consuming and costly, requiring significant investments in infrastructure, equipment, and qualified personnel. Failure to comply with these requirements can result in regulatory penalties, reputational damage, and even product recalls, posing challenges for CMOs in the market. , Global Pharmaceutical Contract Manufacturing Market Competitive Landscape , The global pharmaceutical contract manufacturing market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of pharmaceutical contract manufacturing. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions. , Recent Developments , In January 2023, PharmaCo Solutions announced a strategic partnership with BioGenex Pharmaceuticals to expand its capabilities in biologics manufacturing. The collaboration aims to leverage BioGenex's expertise in biologics development and manufacturing to enhance PharmaCo Solutions' service offerings in the pharmaceutical contract manufacturing market. , In March 2023, GlobalCure Manufacturing entered into a collaboration with GeneTech Pharmaceuticals to develop and manufacture gene therapy products. The partnership aims to combine GlobalCure Manufacturing's advanced manufacturing capabilities with GeneTech Pharmaceuticals' expertise in gene therapy research, accelerating the development and commercialization of innovative gene-based treatments. , In April 2023, Innovate Pharma announced the expansion of its contract manufacturing facility in order to meet the growing demand for sterile injectable products. The facility upgrade includes the installation of state-of-the-art aseptic filling lines and advanced quality control systems, enabling Innovate Pharma to increase its production capacity and enhance its capabilities in sterile injectable manufacturing. , Global Pharmaceutical Contract Manufacturing Key Market Trends , One key market trend in the global market is the increasing demand for outsourcing manufacturing services by pharmaceutical companies. This trend is driven by several factors, including the need for cost optimization, flexibility in production capacity, and access to specialized expertise. Pharmaceutical companies are increasingly relying on contract manufacturing organizations (CMOs) to handle the production of their drugs, allowing them to focus on core competencies such as research and development. , Global Pharmaceutical Contract Manufacturing Market SkyQuest Analysis , SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. , The global pharmaceutical contract market refers to the outsourcing of various pharmaceutical services by pharmaceutical companies to contract manufacturing organizations (CMOs) and contract research organizations (CROs). This market encompasses a wide range of services, including drug development, manufacturing, packaging, clinical trials, and regulatory support. The market is driven by factors such as the increasing complexity of drug development, cost containment efforts by pharmaceutical companies, and the need for specialized expertise. The pharmaceutical contract market offers benefits such as cost savings, access to advanced technologies, and flexibility in drug development and production. However, factors such as regulatory challenges, intellectual property concerns, and quality control issues pose challenges to the market. Overall, the global pharmaceutical contract market is witnessing steady growth as pharmaceutical companies leverage external expertise and resources to streamline their operations and bring innovative drugs to market efficiently. , KEY MARKET SEGMENTS , Type , Active Pharmaceutical Ingredient (API) Manufacturing , Finished Dosage Formulation (FDF) Manufacturing , Packaging and Labeling , Others , By Region , North America , Europe , Asia Pacific , Latin America , Middle East & Africa , KEY MARKET PLAYERS , Lonza Group AG - Switzerland , Catalent, Inc. - United States , Patheon N.V. (Thermo Fisher Scientific Inc.) - United States , Recipharm AB - Sweden , Jubilant Life Sciences Ltd. - India , Boehringer Ingelheim GmbH - Germany , Piramal Pharma Solutions - India , Famar Health Care Services - Greece , Siegfried Holding AG - Switzerland , Dr. Reddy's Laboratories Ltd. - India , Aenova Group - Germany , Fareva - France , CordenPharma International - Switzerland , Almac Group - United Kingdom , Metrics Contract Services - United States , WuXi AppTec Inc. - China , NextPharma Technologies Holding Ltd. - United Kingdom , Cambrex Corporation - United States , Biocon Ltd. - India , Hovione - Portugal .

Speak With Our Analyst

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Pharmaceutical Contract Manufacturing Market

Product ID: UCMIG35I2233

$5,300
BUY NOW GET SAMPLE